Search

everythinglearnresearchcommunity

for

Search:↓

Adalimumab significantly improves quality of life for patients with moderate to severe hidradenitis suppurativa.

Temporal triangular alopecia is a non-scarring hair loss in children, often linked to other health conditions.

Temporal triangular alopecia in infants is mostly seen in males at birth, with unique features that help with diagnosis.

Tofacitinib shows promise for treating alopecia areata with significant hair regrowth and mild side effects.

Isotretinoin reduced inflammation in tufted hair folliculitis, but hair tufting remained.

The guidelines help doctors manage skin problems from certain cancer treatments to improve patients' lives.

Combining TCA with 5-FU is more effective and safer for treating keloids than TCA alone.

Trichohyalin is modified by enzymes to form strong structures in hair cells.

Genetic mutation and carcinogen treatment are both needed for skin cancer to develop in these specific mice.

Using tacalcitol ointment with photodynamic therapy may effectively treat follicular mucinosis with scalp hair loss.

Tjalma Syndrome is a rare condition in people with lupus, causing fluid buildup and high CA-125 levels, but not due to tumors.

Properly administered testosterone therapy is safe and effective but often not covered by insurance.

Temporal triangular alopecia may be linked to sebaceous nevus and shows a new pinkish background feature.

Using both TGA and DTDG in hair straightening reduces hair damage compared to using TGA alone.

Young HS patients often have other physical and mental health issues, and research on HS covers a wide range of topics including genetics, triggers, treatments, and the need for more data.

HAIRCARECUBE TM (HCC) helps hair products work better by getting active ingredients deeper into the hair.

CTHRC1 helps sweat glands recover by rebuilding nearby blood vessels.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Tofacitinib may effectively regrow hair in alopecia totalis patients.

Combining triamcinolone acetonide and immunotherapy can help regrow hair in some alopecia totalis patients.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

Endothelial TLR2 is crucial for timely wound healing, but HFSC TLR2 is not needed.

Doctors often miss Hair Tourniquet Syndrome, which can lead to serious damage if not treated quickly.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

Tofacitinib helps regrow hair in severe alopecia patients, but more research is needed.

Tocilizumab treatment was associated with significant hair regrowth in one patient and temporary hair loss followed by regrowth in another.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Trastuzumab may cause tufted hair folliculitis as a side effect.

Congenital triangular alopecia and vitiligo can occur together, but treatment for one may not affect the other.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.